Monovalent Rotavirus Vaccine Effectiveness and Impact on Rotavirus Hospitalizations in Zanzibar, Tanzania: Data From the First 3 Years After Introduction

Clicks: 374
ID: 114130
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
With data encompassing 3 years before and 3 years after vaccine introduction, our results indicate that successful delivery of RV1 on the current World Health Organization schedule can provide substantial health benefits in a resource-limited setting.
Reference Key
ka2017themonovalent Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Abeid KA;Jani B;Cortese MM;Kamugisha C;Mwenda JM;Pandu AS;Msaada KA;Mohamed AS;Khamis AU;Parashar UD;Saleh AA;;
Journal The Journal of infectious diseases
Year 2017
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/27815381
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't u.s. gov't non-p.h.s. female male Child Infant P.H.S. preschool rotavirus infections / prevention & control* rotavirus vaccines / immunology* vaccines attenuated / administration & dosage attenuated / immunology rotavirus infections / epidemiology* rotavirus vaccines / administration & dosage* hospitalization* pmid:27815381 doi:10.1093/infdis/jiw524 khamis ali abeid bhavin jani abdulhamid a saleh tanzania / epidemiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.